Transcriptomic Immune Profiling: A Precision Path Forward for Immunotherapy in Patients with Cervical Cancer?

Choose the health content that’s right for you, and get it delivered right in your inbox.

Sed sed mi quis lectus lobortis ultricies sed eget dolor. Sed in odio vitae orci condimentum fringilla non id ante. Nulla ac leo blandit lectus placerat pharetra. Integer fermentum faucibus dapibus. Nullam auctor in nunc id suscipit. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Donec vehicula lorem eu enim pulvinar condimentum. Sed rutrum augue lorem.

Pellentesque dictum risus a nisl rhoncus interdum. Pellentesque non sapien nec sapien semper vulputate sit amet sed leo. Aenean eu enim vitae ante eleifend feugiat ac in lacus. Proin nec augue odio. Sed ac feugiat tellus. Aliquam at pellentesque felis, ac sagittis massa. Donec eu pharetra nulla. In egestas rutrum sem, ac dignissim purus viverra eu. Proin nec mauris tortor. Sed viverra varius lacus, vel hendrerit tortor. Vivamus erat tortor, gravida ac ligula vitae, fringilla blandit turpis. Ut pulvinar ligula sit amet eleifend mollis. Duis pulvinar, diam ut fringilla finibus, ante est venenatis erat, et posuere nisl elit malesuada quam. Quisque elementum ligula id tellus sollicitudin scelerisque et et mauris. Curabitur et ipsum eget erat sagittis ultricies. Cras sit amet arcu in mi interdum facilisis quis nec sapien.

View the poster

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma

AdventHealth Clinical Research Unit (CRU) Executive Director and Medical Director of Genitourinary Oncology Guru Sonpavde, MD, co-authored an article on the AMBASSADOR Phase III clinical trial results...

Read Article about "New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma"
News
AdventHealth Involved in Research to Evaluate First Potential Disease-Modifying Treatment for Epileptic Patients with Dravet Syndrome

Under the leadership of principal investigator Ki Hyeong Lee, MD, MS, medical director of AdventHealth for Children’s pediatric epilepsy center in Orlando, AdventHealth Orlando has been one of two...

Read Article about "AdventHealth Involved in Research to Evaluate First Potential Disease-Modifying Treatment for Epileptic Patients with Dravet Syndrome "
News
AdventHealth for Children Collaborating with n-Lorem Foundation to Provide Personalized Treatments to Patients with Nano-rare Genetic Diseases

The n-Lorem Foundation recently selected AdventHealth for Children in Orlando as one of the first institutions in Florida to collaborate with providing personalized antisense oligonucleotide (ASO)...

Read Article about "AdventHealth for Children Collaborating with n-Lorem Foundation to Provide Personalized Treatments to Patients with Nano-rare Genetic Diseases"
View More Articles